TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 105 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,518,000 | -14.8% | 657,496 | -4.3% | 0.08% | -24.1% |
| Q2 2016 | $2,954,000 | +12.3% | 686,921 | +20.9% | 0.11% | +12.5% |
| Q1 2016 | $2,630,000 | -54.2% | 568,001 | -0.9% | 0.10% | -51.5% |
| Q4 2015 | $5,748,000 | -9.4% | 573,101 | -32.6% | 0.20% | +1.0% |
| Q3 2015 | $6,345,000 | -81.0% | 850,601 | +20.5% | 0.20% | -79.3% |
| Q2 2015 | $33,474,000 | +26.8% | 705,601 | -2.1% | 0.95% | +25.4% |
| Q1 2015 | $26,409,000 | +7.5% | 720,781 | +16.5% | 0.76% | +5.4% |
| Q4 2014 | $24,575,000 | +299.5% | 618,860 | +100.7% | 0.72% | +277.4% |
| Q3 2014 | $6,152,000 | – | 308,360 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,940,000 | $19,458,000 | 8.16% |
| HARVEY CAPITAL MANAGEMENT INC | 293,500 | $2,943,000 | 1.16% |
| Rhenman & Partners Asset Management AB | 225,000 | $2,257,000 | 0.34% |
| Granahan Investment Management | 573,101 | $5,748,000 | 0.20% |
| Riverloft Capital Management L.P. | 25,000 | $251,000 | 0.17% |
| A.R.T. Advisors, LLC | 353,527 | $3,545,000 | 0.17% |
| Rock Springs Capital Management LP | 200,000 | $2,006,000 | 0.15% |
| C WorldWide Group Holding A/S | 625,510 | $6,274,000 | 0.11% |
| BB BIOTECH AG | 366,203 | $3,673,000 | 0.10% |
| Gruss Capital Management LP | 300,000 | $3,009,000 | 0.10% |